Diagnostic Difficulties of Mucopolysaccharidosis Type I Mild Forms: Clinical Cases

Diagnostic Difficulties of Mucopolysaccharidosis Type I Mild Forms: Clinical Cases

Mucopolysaccharidosis type I mild forms include Scheie syndrome and Hurler-Scheie syndrome that are characterized by slow progression, intact intelligence, and primarily effect on visual organ, musculoskeletal and cardiovascular systems. Early diagnostics, multidisciplinary approach to examination a...

Full description

Bibliographic Details
Main Authors:	Nato D. Vashakmadze, Leyla S. Namazova-Baranova, Natalia V. Zhurkova, Ekaterina Yu. Zakharova, Elena J. Voskobaeva, Marina A. Babaikina, Lyudmila M. Mikhaylova
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2020-06-01
Series:	Voprosy Sovremennoj Pediatrii
Subjects:	mucopolysaccharidosis scheie syndrome hurler-scheie syndrome alpha-l-iduronidase diagnostics
Online Access:	https://vsp.spr-journal.ru/jour/article/view/2379

Similar Items

Orthopedic Pathology in Children with Mucopolysaccharidosis Type I
by: Nato D. Vashakmadze, et al.
Published: (2016-12-01)

Mucopolissacaridose tipo I: avaliação de um novo instrumento para classificação fenotípica
by: Federhen, Andressa
Published: (2012)

Mucopolissacaridose tipo I: avaliação de um novo instrumento para classificação fenotípica
by: Federhen, Andressa
Published: (2012)

Mucopolissacaridose tipo I: avaliação de um novo instrumento para classificação fenotípica
by: Federhen, Andressa
Published: (2012)

A deletion of IDUA exon 10 in a family of Golden Retriever dogs with an attenuated form of mucopolysaccharidosis type I
by: Kiterie M. E. Faller, et al.
Published: (2020-09-01)

A Humoral Immune Response Alters the Distribution of Enzyme Replacement Therapy in Murine Mucopolysaccharidosis Type I
by: Steven Q. Le, et al.
Published: (2018-03-01)

Mucopolysaccharidosis Type I
by: Francyne Kubaski, et al.
Published: (2020-03-01)

Genotypic and bioinformatic evaluation of the alpha-l-iduronidase gene and protein in patients with mucopolysaccharidosis type I from Colombia, Ecuador and Peru
by: Tatiana Pineda, et al.
Published: (2014-01-01)

Hurler–Scheie syndrome in Niger: a case series
by: Hamid Assadeck, et al.
Published: (2019-04-01)

Evaluation of Multiple Methods for Quantification of Glycosaminoaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis-I
by: Zackary M. Herbst, et al.
Published: (2020-08-01)

Bull's eye maculopathy and subfoveal deposition in two mucopolysaccharidosis type I patients on long-term enzyme replacement therapy
by: Heather G. Mack, et al.
Published: (2018-03-01)

Rare cases of mucopolysaccharidosis type I in children with Hurler and Hurler-Scheie syndromes
by: A. E. Babushkin, et al.
Published: (2018-10-01)

Mucopolysaccharridosis type 1 and the challenges in managing this rare genetic disorder in the resource poor setting
by: A. N. Onyiriuka, et al.
Published: (2016-02-01)

Current Practices for U.S. Newborn Screening of Pompe Disease and MPSI
by: Elizabeth G. Ames, et al.
Published: (2020-09-01)

Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type I
by: Kenta Sugiura, et al.
Published: (2020-12-01)

Early detection of median nerve compression by Electroneurography can improve outcome in children with Mucopolysaccharidoses
by: Kim Maincent, et al.
Published: (2018-11-01)

Incidental diagnosis of mucopolysaccharidosis type I in an infant with chronic intestinal pseudoobstruction by exome sequencing
by: Auriane Cospain, et al.
Published: (2020-09-01)

Manifestações oculares da síndrome de Scheie: Relato de cinco casos
by: Diane Ruschel Marinho, et al.

Direct gene transfer to the CNS prevents emergence of neurologic disease in a murine model of mucopolysaccharidosis type I
by: Daniel A. Wolf, et al.
Published: (2011-07-01)

In Vivo Confocal Microscopy and Anterior Segment Optical Coherence Tomography Findings in Two Cases with Mucopolysaccharidoses
by: Yalçın Karaküçük, et al.
Published: (2020-06-01)

Enzyme Replacement Therapy and Hematopoietic Stem Cell Transplantation Results in Patients with Hurler Syndrome: Clinical Cases
by: Nato D. Vashakmadze, et al.
Published: (2019-09-01)

Mucopolysaccharidosis type I Hurler-Scheie syndrome: A rare case report
by: Ramesh Tatapudi, et al.
Published: (2011-01-01)

Elements of lentiviral vector design toward gene therapy for treating mucopolysaccharidosis I
by: Li Ou, et al.
Published: (2016-09-01)

An online survey on burden of illness among families with post-stem cell transplant mucopolysaccharidosis type I children in the United States
by: Therese Conner, et al.
Published: (2019-02-01)

Mucopolisacaridosis (síndrome de Hunter)
by: Xidix Toirac Cabrera, et al.

Biomarkers for prediction of skeletal disease progression in mucopolysaccharidosis type I
by: Troy C. Lund, et al.
Published: (2021-03-01)

Estabelecimento de um novo método de diagnóstico molecular para mucopolissacaridose tipo I
by: Almeida, Andresa Cardoso Grandini
Published: (2011)

Estabelecimento de um novo método de diagnóstico molecular para mucopolissacaridose tipo I
by: Almeida, Andresa Cardoso Grandini
Published: (2011)

Estabelecimento de um novo método de diagnóstico molecular para mucopolissacaridose tipo I
by: Almeida, Andresa Cardoso Grandini
Published: (2011)

Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology
by: Christiane S. Hampe, et al.
Published: (2020-08-01)

Anesthetic management in children with Hurler′s syndrome undergoing emergency ventriculoperitoneal shunt surgery
by: Nidhi Gupta, et al.
Published: (2012-01-01)

Lower Exposure to Busulfan Allows for Stable Engraftment of Donor Hematopoietic Stem Cells in Children with Mucopolysaccharidosis Type I: A Case Report of Four Patients
by: Praveen Shukla, et al.
Published: (2020-08-01)

Transcranial pulsed ultrasound facilitates brain uptake of laronidase in enzyme replacement therapy for Mucopolysaccharidosis type I disease
by: Yu-Hone Hsu, et al.
Published: (2017-06-01)

Development of a newborn screening tool for mucopolysaccharidosis type I based on bivariate normal limits: Using glycosaminoglycan and alpha‐L‐iduronidase determinations on dried blood spots to predict symptoms
by: Thomas J. Langan, et al.
Published: (2020-03-01)

Immune tolerance induction for laronidase treatment in mucopolysaccharidosis I
by: Roberto Giugliani, et al.
Published: (2017-03-01)

Mucopolysaccharidosis type II: Enzyme Replacement Therapy Efficiency
by: Nato D. Vashakmadze, et al.
Published: (2020-02-01)

Three novel α-L-iduronidase mutations in 10 unrelated Chinese mucopolysaccharidosis type I families
by: Luning Sun, et al.
Published: (2011-01-01)

Three novel α-L-iduronidase mutations in 10 unrelated Chinese mucopolysaccharidosis type I families
by: Luning Sun, et al.
Published: (2011-01-01)

Mucopolysaccharidosis Type I: Current Treatments,Limitations and Prospects for Improvement
by: Christiane S. Hampe, et al.
Published: (2021-01-01)

Long-term reestablishment of alpha-L-iduronidase activity in MPS I fibroblasts after non-viral gene transfer
by: Fabiano de Oliveira Poswar, et al.
Published: (2017-12-01)